2017
DOI: 10.1016/j.freeradbiomed.2017.10.242
|View full text |Cite
|
Sign up to set email alerts
|

RT01, A Novel Derivative of the Mitochondria-targeted Hydrogen Sulfide Donor AP39, Reversed Hyperglycaemia-induced Mitochondrial Dysfunction in Murine Brain Microvascular Endothelial Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In addition, AP39 and AP123 treatment reduced mitochondrial oxidative free radicals ( Gero et al., 2016 ). Similarly, RT01, a novel derivative of AP39, reversed hyperglycemia-induced mitochondrial hyperpolarization, oxidant production, and increased synthesis of ATP, leading to restoration of mitochondrial function in murine brain microvascular endothelial cells ( Waters et al., 2017 ).…”
Section: H 2 S Research Tools: Inhibitors Of H mentioning
confidence: 99%
“…In addition, AP39 and AP123 treatment reduced mitochondrial oxidative free radicals ( Gero et al., 2016 ). Similarly, RT01, a novel derivative of AP39, reversed hyperglycemia-induced mitochondrial hyperpolarization, oxidant production, and increased synthesis of ATP, leading to restoration of mitochondrial function in murine brain microvascular endothelial cells ( Waters et al., 2017 ).…”
Section: H 2 S Research Tools: Inhibitors Of H mentioning
confidence: 99%